These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 34958892)
1. Tumor-stroma TGF-β1-THBS2 feedback circuit drives pancreatic ductal adenocarcinoma progression via integrin α Nan P; Dong X; Bai X; Lu H; Liu F; Sun Y; Zhao X Cancer Lett; 2022 Mar; 528():59-75. PubMed ID: 34958892 [TBL] [Abstract][Full Text] [Related]
2. Modulation of Cancer-Associated Fibrotic Stroma by An Integrin α Turaga RC; Sharma M; Mishra F; Krasinskas A; Yuan Y; Yang JJ; Wang S; Liu C; Li S; Liu ZR Cell Mol Gastroenterol Hepatol; 2021; 11(1):161-179. PubMed ID: 32810598 [TBL] [Abstract][Full Text] [Related]
3. circCUL2 induces an inflammatory CAF phenotype in pancreatic ductal adenocarcinoma via the activation of the MyD88-dependent NF-κB signaling pathway. Zheng S; Hu C; Lin H; Li G; Xia R; Zhang X; Su D; Li Z; Zhou Q; Chen R J Exp Clin Cancer Res; 2022 Feb; 41(1):71. PubMed ID: 35189958 [TBL] [Abstract][Full Text] [Related]
4. Chemotherapy-Induced Inflammatory Gene Signature and Protumorigenic Phenotype in Pancreatic CAFs via Stress-Associated MAPK. Toste PA; Nguyen AH; Kadera BE; Duong M; Wu N; Gawlas I; Tran LM; Bikhchandani M; Li L; Patel SG; Dawson DW; Donahue TR Mol Cancer Res; 2016 May; 14(5):437-47. PubMed ID: 26979711 [TBL] [Abstract][Full Text] [Related]
6. Palladin isoforms 3 and 4 regulate cancer-associated fibroblast pro-tumor functions in pancreatic ductal adenocarcinoma. Alexander JI; Vendramini-Costa DB; Francescone R; Luong T; Franco-Barraza J; Shah N; Gardiner JC; Nicolas E; Raghavan KS; Cukierman E Sci Rep; 2021 Feb; 11(1):3802. PubMed ID: 33589694 [TBL] [Abstract][Full Text] [Related]
7. Thrombospondin 4/integrin α2/HSF1 axis promotes proliferation and cancer stem-like traits of gallbladder cancer by enhancing reciprocal crosstalk between cancer-associated fibroblasts and tumor cells. Shi Y; Sun L; Zhang R; Hu Y; Wu Y; Dong X; Dong D; Chen C; Geng Z; Li E; Fan Y J Exp Clin Cancer Res; 2021 Jan; 40(1):14. PubMed ID: 33407730 [TBL] [Abstract][Full Text] [Related]
9. Up-regulation of L1CAM in pancreatic duct cells is transforming growth factor beta1- and slug-dependent: role in malignant transformation of pancreatic cancer. Geismann C; Morscheck M; Koch D; Bergmann F; Ungefroren H; Arlt A; Tsao MS; Bachem MG; Altevogt P; Sipos B; Fölsch UR; Schäfer H; Müerköster SS Cancer Res; 2009 May; 69(10):4517-26. PubMed ID: 19435915 [TBL] [Abstract][Full Text] [Related]
10. Differential roles of Smad2 and Smad3 in the regulation of TGF-β1-mediated growth inhibition and cell migration in pancreatic ductal adenocarcinoma cells: control by Rac1. Ungefroren H; Groth S; Sebens S; Lehnert H; Gieseler F; Fändrich F Mol Cancer; 2011 May; 10():67. PubMed ID: 21624123 [TBL] [Abstract][Full Text] [Related]
11. [Epithelial-stromal interactions in pancreatic adenocarcinoma: the role of stroma in disease progression]. Kuznetsova AV; Popova OP; Astakhov DA; Ivanov YV; Panchenkov DN; Ivanov AA Arkh Patol; 2022; 84(5):65-70. PubMed ID: 36178225 [TBL] [Abstract][Full Text] [Related]
12. Macrophage-derived exosomal microRNA-501-3p promotes progression of pancreatic ductal adenocarcinoma through the TGFBR3-mediated TGF-β signaling pathway. Yin Z; Ma T; Huang B; Lin L; Zhou Y; Yan J; Zou Y; Chen S J Exp Clin Cancer Res; 2019 Jul; 38(1):310. PubMed ID: 31307515 [TBL] [Abstract][Full Text] [Related]
13. Extracellular matrix-mediated membrane-type 1 matrix metalloproteinase expression in pancreatic ductal cells is regulated by transforming growth factor-beta1. Ottaviano AJ; Sun L; Ananthanarayanan V; Munshi HG Cancer Res; 2006 Jul; 66(14):7032-40. PubMed ID: 16849548 [TBL] [Abstract][Full Text] [Related]
14. Inhibiting YAP expression suppresses pancreatic cancer progression by disrupting tumor-stromal interactions. Jiang Z; Zhou C; Cheng L; Yan B; Chen K; Chen X; Zong L; Lei J; Duan W; Xu Q; Li X; Wang Z; Ma Q; Ma J J Exp Clin Cancer Res; 2018 Mar; 37(1):69. PubMed ID: 29587800 [TBL] [Abstract][Full Text] [Related]
15. Pathophysiological role of microRNA-29 in pancreatic cancer stroma. Kwon JJ; Nabinger SC; Vega Z; Sahu SS; Alluri RK; Abdul-Sater Z; Yu Z; Gore J; Nalepa G; Saxena R; Korc M; Kota J Sci Rep; 2015 Jun; 5():11450. PubMed ID: 26095125 [TBL] [Abstract][Full Text] [Related]
16. Unique metabolic features of pancreatic cancer stroma: relevance to the tumor compartment, prognosis, and invasive potential. Knudsen ES; Balaji U; Freinkman E; McCue P; Witkiewicz AK Oncotarget; 2016 Nov; 7(48):78396-78411. PubMed ID: 27623078 [TBL] [Abstract][Full Text] [Related]
17. Stromal remodeling by the BET bromodomain inhibitor JQ1 suppresses the progression of human pancreatic cancer. Yamamoto K; Tateishi K; Kudo Y; Hoshikawa M; Tanaka M; Nakatsuka T; Fujiwara H; Miyabayashi K; Takahashi R; Tanaka Y; Ijichi H; Nakai Y; Isayama H; Morishita Y; Aoki T; Sakamoto Y; Hasegawa K; Kokudo N; Fukayama M; Koike K Oncotarget; 2016 Sep; 7(38):61469-61484. PubMed ID: 27528027 [TBL] [Abstract][Full Text] [Related]
18. The anti-oxidative transcription factor Nuclear factor E2 related factor-2 (Nrf2) counteracts TGF-β1 mediated growth inhibition of pancreatic ductal epithelial cells -Nrf2 as determinant of pro-tumorigenic functions of TGF-β1. Genrich G; Kruppa M; Lenk L; Helm O; Broich A; Freitag-Wolf S; Röcken C; Sipos B; Schäfer H; Sebens S BMC Cancer; 2016 Feb; 16():155. PubMed ID: 26915435 [TBL] [Abstract][Full Text] [Related]
19. IL1-Induced JAK/STAT Signaling Is Antagonized by TGFβ to Shape CAF Heterogeneity in Pancreatic Ductal Adenocarcinoma. Biffi G; Oni TE; Spielman B; Hao Y; Elyada E; Park Y; Preall J; Tuveson DA Cancer Discov; 2019 Feb; 9(2):282-301. PubMed ID: 30366930 [TBL] [Abstract][Full Text] [Related]
20. Bone marrow-derived macrophages converted into cancer-associated fibroblast-like cells promote pancreatic cancer progression. Iwamoto C; Ohuchida K; Shinkawa T; Okuda S; Otsubo Y; Okumura T; Sagara A; Koikawa K; Ando Y; Shindo K; Ikenaga N; Nakata K; Moriyama T; Miyasaka Y; Ohtsuka T; Eto M; Akashi K; Nakamura M Cancer Lett; 2021 Aug; 512():15-27. PubMed ID: 33961925 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]